To test if the Bcan-Ntrk1 gene fusion was sufficient to drive glioma formation we injected intracranially into NOD/SCID mice the p53-null TVA-Cas9 NSCs infected with the RCAS-gRNA-pair. The gene discussed is NTRK1; the disease is central nervous system cancer.